Aurobindo Pharma's subsidiary, Eugia Steriles, has received its first product approval from the USFDA for Lidocaine Hydrochloride Injection, a generic anaesthesia medication.
New Delhi, Sep 11 (PTI) Aurobindo Pharma on Wednesday said its unit has received the first product approval from the US Food and Drug Administration for a generic anaesthesia medication.
The new injectable facility of Eugia Steriles, a subsidiary of Eugia Pharma Specialities and a stepdown unit of the company, situated at Anakapalli District of Andhra Pradesh was inspected by the US FDA from March 28 to April 5 this year.
The plant has now received its first product approval from the USFDA for Lidocaine Hydrochloride Injection, Aurobindo Pharma said in a regulatory filing.
Shares of Aurobindo Pharma on Wednesday ended 0.74 per cent down at Rs 1,507.20 apiece on the BSE.
Home » Market News » Aurobindo Pharma Gets First USFDA Approval for Generic Anaesthesia
DISCLAIMER - This article is from a syndicated feed. The original source is responsible for accuracy, views & content ownership. Views expressed may not reflect those of rediff.com India Limited.
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback